MENU
HROW
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Harrow (HROW) Ownership - Who owns Harrow?

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more

Profile

Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
467.85M
P/E Ratio
39.53
Total Cash
82.77M
Projected Growth
N/A
Total Debt
190.5M
Revenue
130.19M
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash/Share
2.34
Total Debt/Equity
N/A
Revenue/Share
3.99 USD as % of share price

Fundamentals

HROW
Capitalization
468M
P/E Ratio
39.53
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash
82.8M
Total Cash/Share
2.34
Total Debt
191M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.99%
Revenue
130M
ROE
N/A
Book Value
70.8M
P/B Ratio
6.40
Cash Flow
N/A
Earnings
-0.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
35K
Current Ratio
2.83
Current Revenue Per Employee
167534.56
Dividends Per Share - Security
N/A
EBITDA
9.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
68.91
Revenue To Assets
-10.40
Shares Held By Institutions
343M
Shares Outstanding - Current
35.4M
Total Liabilities
242M
Total Volume MTD
N/A
Value
-1
Gain YTD
-21.878
View a ticker or compare two or three
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com